Transplantation, AutologousHematopoietic Stem Cell TransplantationTransplantation, HomologousBone Marrow TransplantationTransplantation ConditioningHematopoietic Stem Cell MobilizationHodgkin DiseaseMultiple MyelomaRecurrenceTreatment OutcomeRetrospective StudiesSurvival AnalysisKidney TransplantationBlood Transfusion, AutologousTransplantsGraft RejectionGraft SurvivalImmunosuppressive AgentsHeart TransplantationTissue DonorsTransplantationLung TransplantationTime FactorsStem Cell TransplantationTissue and Organ ProcurementCyclosporineImmunosuppressionCombined Modality TherapyPostoperative ComplicationsTacrolimusLiving DonorsWaiting ListsMelphalanCytomegalovirus InfectionsFollow-Up StudiesHistocompatibility TestingGraft vs Host DiseasePeripheral Blood Stem Cell TransplantationFetal Tissue TransplantationT-LymphocytesTransplantation ImmunologyCyclophosphamideWhole-Body IrradiationLymphoma, Non-HodgkinBone Marrow PurgingMycophenolic AcidSurvival RateAntineoplastic Combined Chemotherapy ProtocolsImmunocompromised HostCadaverLymphocyte Culture Test, MixedKidney Failure, ChronicHLA AntigensCytotoxicity, ImmunologicHematologic NeoplasmsCarmustineCell TransplantationLiver FailureLymphocyte ActivationRisk FactorsProspective StudiesT-Lymphocytes, CytotoxicSalvage TherapyDisease-Free SurvivalHeart-Lung TransplantationHistocompatibilityTransplantation, HeterotopicBrain Tissue TransplantationOpportunistic InfectionsEtoposideCells, CulturedAntilymphocyte SerumAntigens, CD34Remission InductionPrognosisTransplantation, IsogeneicAcute DiseaseBusulfanCytomegalovirusBronchiolitis ObliteransThiotepaAntigens, NeoplasmDendritic CellsTransplantation ToleranceBiopsyHematopoietic Stem CellsImmunotherapy, AdoptiveAntibodies, MonoclonalLeukemiaLymphoproliferative DisordersTissue TransplantationImmunotherapyIsoantibodiesKidneyCancer VaccinesCytarabineBone TransplantationBK VirusFlow CytometryLymphocytes